JP2006515748A5 - - Google Patents

Info

Publication number

JP2006515748A5

JP2006515748A5 JP2004552090A JP2004552090A JP2006515748A5 JP 2006515748 A5 JP2006515748 A5 JP 2006515748A5 JP 2004552090 A JP2004552090 A JP 2004552090A JP 2004552090 A JP2004552090 A JP 2004552090A JP 2006515748 A5 JP2006515748 A5 JP 2006515748A5

Authority

JP

Japan

Prior art keywords

seq

sequence number

sequence

polypeptide

antibody

Prior art date

2003-11-12

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 108090000765 processed proteins & peptides Proteins 0.000 claims 33
• 229920001184 polypeptide Polymers 0.000 claims 32
• 102000004196 processed proteins & peptides Human genes 0.000 claims 32
• 210000004027 cell Anatomy 0.000 claims 19
• 241000124008 Mammalia Species 0.000 claims 11
• 239000000523 sample Substances 0.000 claims 9
• 150000001875 compounds Chemical class 0.000 claims 8
• 150000007523 nucleic acids Chemical class 0.000 claims 8
• 201000010099 disease Diseases 0.000 claims 7
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 7
• 238000000034 method Methods 0.000 claims 6
• 108090000623 proteins and genes Proteins 0.000 claims 6
• 108020004707 nucleic acids Proteins 0.000 claims 5
• 102000039446 nucleic acids Human genes 0.000 claims 5
• 125000003275 alpha amino acid group Chemical group 0.000 claims 4
• 239000005557 antagonist Substances 0.000 claims 4
• 239000013068 control sample Substances 0.000 claims 4
• 239000003814 drug Substances 0.000 claims 4
• 230000028993 immune response Effects 0.000 claims 4
• 239000002773 nucleotide Substances 0.000 claims 4
• 125000003729 nucleotide group Chemical group 0.000 claims 4
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 3
• 108091028043 Nucleic acid sequence Proteins 0.000 claims 3
• 239000000556 agonist Substances 0.000 claims 3
• 230000015572 biosynthetic process Effects 0.000 claims 2
• 229940079593 drug Drugs 0.000 claims 2
• 230000000694 effects Effects 0.000 claims 2
• 230000002757 inflammatory effect Effects 0.000 claims 2
• 238000004519 manufacturing process Methods 0.000 claims 2
• 230000004043 responsiveness Effects 0.000 claims 2
• 108091026890 Coding region Proteins 0.000 claims 1
• 206010012442 Dermatitis contact Diseases 0.000 claims 1
• 206010048768 Dermatosis Diseases 0.000 claims 1
• 206010015218 Erythema multiforme Diseases 0.000 claims 1
• 241000588724 Escherichia coli Species 0.000 claims 1
• 108060003951 Immunoglobulin Proteins 0.000 claims 1
• 208000003456 Juvenile Arthritis Diseases 0.000 claims 1
• 208000008771 Lymphadenopathy Diseases 0.000 claims 1
• 201000002481 Myositis Diseases 0.000 claims 1
• 201000004681 Psoriasis Diseases 0.000 claims 1
• 240000004808 Saccharomyces cerevisiae Species 0.000 claims 1
• 208000021386 Sjogren Syndrome Diseases 0.000 claims 1
• 206010041660 Splenomegaly Diseases 0.000 claims 1
• 208000006045 Spondylarthropathies Diseases 0.000 claims 1
• 201000009594 Systemic Scleroderma Diseases 0.000 claims 1
• 208000004732 Systemic Vasculitis Diseases 0.000 claims 1
• 206010042953 Systemic sclerosis Diseases 0.000 claims 1
• 206010047115 Vasculitis Diseases 0.000 claims 1
• 230000000692 anti-sense effect Effects 0.000 claims 1
• 230000001363 autoimmune Effects 0.000 claims 1
• 230000005784 autoimmunity Effects 0.000 claims 1
• 208000019748 bullous skin disease Diseases 0.000 claims 1
• 238000004113 cell culture Methods 0.000 claims 1
• 239000003795 chemical substances by application Substances 0.000 claims 1
• 210000004978 chinese hamster ovary cell Anatomy 0.000 claims 1
• 208000010247 contact dermatitis Diseases 0.000 claims 1
• 238000012258 culturing Methods 0.000 claims 1
• 239000003937 drug carrier Substances 0.000 claims 1
• 208000007475 hemolytic anemia Diseases 0.000 claims 1
• 208000013643 idiopathic inflammatory myopathy Diseases 0.000 claims 1
• 102000018358 immunoglobulin Human genes 0.000 claims 1
• 201000002364 leukopenia Diseases 0.000 claims 1
• 231100001022 leukopenia Toxicity 0.000 claims 1
• 208000018555 lymphatic system disease Diseases 0.000 claims 1
• 230000001404 mediated effect Effects 0.000 claims 1
• 201000008482 osteoarthritis Diseases 0.000 claims 1
• 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
• 201000000306 sarcoidosis Diseases 0.000 claims 1
• 208000017520 skin disease Diseases 0.000 claims 1
• 201000005671 spondyloarthropathy Diseases 0.000 claims 1
• 230000004936 stimulating effect Effects 0.000 claims 1
• 201000000596 systemic lupus erythematosus Diseases 0.000 claims 1